NOTE: Before answering the questions, read the “Background” and watch the video under “Resources.”

1. List the who, what, where and when of the news report.

2. a) How many volunteers are participating in the first phase of Inovio’s testing of its coronavirus vaccine?
b) When will volunteers receive the two does of the INO-4800 DNA vaccine?
c) When will the initial data from the trial be available?

3. a) What is the purpose of the first trial phase?
b) What will the second clinical trial phase determine?

4. How many doses of the vaccine does Inovio plan on producing by December?

5. If these first phases are successful, how long would it usually take the FDA to approve it for official use?

6. For what reason is the company preparing such a large number of doses before they know if the vaccine will be effective?

7. Inovio’s is the second vaccine to begin clinical trials. In addition, there are several other companies close to starting (or in other countries to have started) trials. How does this news encourage you?